{
    "ticker": "TBIO",
    "name": "Therapeutic Solutions International, Inc.",
    "description": "Therapeutic Solutions International, Inc. is a biotechnology company focused on the development of innovative therapies for the treatment of various medical conditions. Founded in 2013, the company is dedicated to advancing the field of regenerative medicine and immunotherapy to improve patient outcomes. TBIO is engaged in the research and development of novel cellular therapies, with a particular emphasis on harnessing the power of the immune system to combat diseases such as cancer and neurodegenerative disorders. The company\u2019s proprietary platform leverages advanced technologies in stem cell research and biomarker identification, allowing for the creation of targeted treatments that are tailored to individual patient needs. Therapeutic Solutions International's mission is to provide safe and effective therapeutic solutions that enhance the quality of life for patients globally. With a strong emphasis on scientific collaboration and clinical research, the company is committed to transforming healthcare through innovative therapeutic approaches.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Elk Grove, California, USA",
    "founded": "2013",
    "website": "https://www.therapeuticsolutionsint.com",
    "ceo": "Timothy Warbington",
    "social_media": {
        "twitter": "https://twitter.com/TherapeuticSol",
        "linkedin": "https://www.linkedin.com/company/therapeutic-solutions-international/"
    },
    "investor_relations": "https://www.therapeuticsolutionsint.com/investor-relations",
    "key_executives": [
        {
            "name": "Timothy Warbington",
            "position": "CEO"
        },
        {
            "name": "James C. McNulty",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "Cellular Therapies",
                "Immunotherapy Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Therapeutic Solutions International, Inc. | Innovative Biotech Solutions",
        "meta_description": "Explore Therapeutic Solutions International, Inc., a leader in biotechnology focused on regenerative medicine and immunotherapy for various diseases.",
        "keywords": [
            "Therapeutic Solutions",
            "Biotechnology",
            "Regenerative Medicine",
            "Immunotherapy",
            "Cancer Treatment",
            "Neurodegenerative Disorders"
        ]
    },
    "faq": [
        {
            "question": "What is Therapeutic Solutions International known for?",
            "answer": "Therapeutic Solutions International is known for its innovative therapies in regenerative medicine and immunotherapy."
        },
        {
            "question": "Who is the CEO of Therapeutic Solutions International?",
            "answer": "Timothy Warbington is the CEO of Therapeutic Solutions International, Inc."
        },
        {
            "question": "Where is Therapeutic Solutions International headquartered?",
            "answer": "The company is headquartered in Elk Grove, California, USA."
        },
        {
            "question": "What are the main products of Therapeutic Solutions International?",
            "answer": "The main products include cellular therapies and immunotherapy solutions."
        },
        {
            "question": "When was Therapeutic Solutions International founded?",
            "answer": "The company was founded in 2013."
        }
    ],
    "competitors": [
        "NVAX",
        "CRMD",
        "CARA"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "VRTX"
    ]
}